256 related articles for article (PubMed ID: 32553631)
1. RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation.
Luo Z; Ye X; Shou F; Cheng Y; Li F; Wang G
Biochem Biophys Res Commun; 2020 Sep; 530(2):425-431. PubMed ID: 32553631
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation.
Luo Z; Ye X; Cheng Y; Li F; Shou F; Wang G
Biochem Biophys Res Commun; 2021 Jun; 556():106-113. PubMed ID: 33839405
[TBL] [Abstract][Full Text] [Related]
3. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
4. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
[TBL] [Abstract][Full Text] [Related]
5. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
6. HOIL-1L functions as the PKCζ ubiquitin ligase to promote lung tumor growth.
Queisser MA; Dada LA; Deiss-Yehiely N; Angulo M; Zhou G; Kouri FM; Knab LM; Liu J; Stegh AH; DeCamp MM; Budinger GR; Chandel NS; Ciechanover A; Iwai K; Sznajder JI
Am J Respir Crit Care Med; 2014 Sep; 190(6):688-98. PubMed ID: 25118570
[TBL] [Abstract][Full Text] [Related]
7. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
Yang G; Gong Y; Wang Q; Wang L; Zhang X
Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
[TBL] [Abstract][Full Text] [Related]
8. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
10. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells.
Liu Z; Xu L
BMB Rep; 2018 Dec; 51(12):642-647. PubMed ID: 30545437
[TBL] [Abstract][Full Text] [Related]
11. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
12. TRIM65 negatively regulates p53 through ubiquitination.
Li Y; Ma C; Zhou T; Liu Y; Sun L; Yu Z
Biochem Biophys Res Commun; 2016 Apr; 473(1):278-282. PubMed ID: 27012201
[TBL] [Abstract][Full Text] [Related]
13. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma.
Liu Y; Zhou Y; Zhang P; Li X; Duan C; Zhang C
Cell Death Differ; 2021 Mar; 28(3):1026-1040. PubMed ID: 33082516
[TBL] [Abstract][Full Text] [Related]
14. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
Zhao X; Wu X; Wang H; Yu H; Wang J
Mol Carcinog; 2020 Aug; 59(8):1000-1011. PubMed ID: 32511815
[TBL] [Abstract][Full Text] [Related]
15. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
17. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
[TBL] [Abstract][Full Text] [Related]
18. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
19. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
20. HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.
Yang D; Cheng D; Tu Q; Yang H; Sun B; Yan L; Dai H; Luo J; Mao B; Cao Y; Yu X; Jiang H; Zhao X
Theranostics; 2018; 8(13):3517-3529. PubMed ID: 30026863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
